Donaldson Company (DCI) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
9 Apr, 2026Executive summary
Achieved record Q2 sales of $896 million, up 3% year-over-year, driven by favorable currency and pricing, with growth across all segments despite volume declines.
Announced the acquisition of Facet for $820 million, the largest in company history, expected to close in the second half of fiscal 2026 and expand the filtration portfolio in aerospace, defense, and power generation.
Leadership transition: COO Richard Lewis named as incoming President and CEO, with Tod Carpenter moving to Executive Chairman.
Returned $51 million to shareholders via dividends and share repurchases in Q2; $108.6 million repurchased year-to-date.
Financial highlights
Q2 operating margin was 14%, down from 15.2% last year, due to gross margin pressure and operational inefficiencies; adjusted operating margin was 14.0%.
Adjusted EPS was $0.83, flat year-over-year; diluted EPS was $0.78, down from $0.79.
Gross margin declined to 33.5% from 35.2% last year; adjusted gross margin was 33.7%.
Free cash flow for Q2 was $18 million, down from $71.5 million a year ago; adjusted free cash flow conversion was 18% in Q2.
Net leverage ratio at 0.7x, expected to rise to 1.7x post-Facet acquisition; total debt as of January 31, 2026, was $680.8 million.
Outlook and guidance
Fiscal 2026 sales expected to reach a record $3.8 billion, with 1%–5% growth across segments.
Adjusted operating margin guidance revised to 16.0%–16.4%, still a record level.
Adjusted EPS forecasted at $3.93–$4.01, with 8% growth at the midpoint.
Life Sciences segment expected to grow 5%–9% for FY26; Mobile sales expected to grow 2%–6%.
No additional share repurchases planned in the second half due to Facet acquisition.
Latest events from Donaldson Company
- Record sales and margin growth driven by innovation, global reach, and strategic acquisitions.DCI
47th Annual Raymond James Institutional Investor Conference4 Mar 2026 - Record results and strong outlook driven by aftermarket growth, technology, and disciplined capital strategy.DCI
Morgan Stanley’s 13th Annual Laguna Conference3 Feb 2026 - Life Sciences and innovation drive growth, with record margins and expanding global opportunities.DCI
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Record Q3 sales, margin expansion, and raised EPS guidance highlight robust growth.DCI
Q3 202431 Jan 2026 - Proprietary technology, global expansion, and strategic investments drive growth and resilience.DCI
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Record sales, margin expansion, and robust Aftermarket growth drive FY24 earnings higher.DCI
Q4 202423 Jan 2026 - Technology-driven growth, digitalization, and Life Sciences expansion fuel strong financial outlook.DCI
Jefferies Global Industrial Conference 202422 Jan 2026 - Technology-driven growth, M&A, and aftermarket strength fuel margin and share gains.DCI
Morgan Stanley‘s 12th Annual Laguna Conference 202420 Jan 2026 - Record sales, margin growth, and Life Sciences expansion drive future-focused strategy.DCI
CL King's 22nd Annual Best Ideas Conference 202420 Jan 2026